The FDA also notes limited clinical data for this compound
In several robust trials, a marked decrease in the incidence of acute respiratory disease, ischemic heart disease, hypertension disease, pulmonary fibrosis, coronary artery disease, diabetes mellitus, Alzeimers disease, deforming osteoarthrosis, and osteoporosis was observed as compared to control animals 6
A deeper understanding of glycines interaction with glutamatergic neurotransmission could contribute to novel therapeutic interventions for CNS disorders
New York, McGraw-Hill, 1987 Schwedes U, Althoff PH, Klempa L, Leuschner L, Mothes L, Raptis S, Wdowinski J, Usadel KH: Effect of somatostatin on bile induced acute haemorrhagic pancreatitis in the dog